Indications and Purposes
| 1 Indications And Usage Rytary Is Indicated For The Treatment Of Parkinson's Disease, Post-Encephalitic Parkinsonism, And Parkinsonism That May Follow Carbon Monoxide Intoxication Or Manganese Intoxication. Rytary Is A Combination Of Carbidopa (an Aromatic Amino Acid Decarboxylation Inhibitor) And Levodopa (an Aromatic Amino Acid) Indicated For The Treatment Of Parkinson's Disease, Post-Encephalitic Parkinsonism, And Parkinsonism That May Follow Carbon Monoxide Intoxication Or Manganese Intoxication ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Carbidopa |
|
ZINC19168887 |
| 2. Levodopa |
|
ZINC895199 |